Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trial (vol 9, 22, 2016)

Download
Author
Foss, F; Horwitz, S; Pro, B; Prince, HM; Sokol, L; Balser, B; Wolfson, J; Coiffier, BDate
2017-09-18Source Title
Journal of Hematology and OncologyPublisher
BIOMED CENTRAL LTDUniversity of Melbourne Author/s
Prince, HenryAffiliation
Medicine and RadiologyMetadata
Show full item recordDocument Type
Journal ArticleCitations
Foss, F., Horwitz, S., Pro, B., Prince, H. M., Sokol, L., Balser, B., Wolfson, J. & Coiffier, B. (2017). Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trial (vol 9, 22, 2016). JOURNAL OF HEMATOLOGY & ONCOLOGY, 10 (1), https://doi.org/10.1186/s13045-017-0518-8.Access Status
Open AccessExport Reference in RIS Format
Endnote
- Click on "Export Reference in RIS Format" and choose "open with... Endnote".
Refworks
- Click on "Export Reference in RIS Format". Login to Refworks, go to References => Import References